Cargando…

Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells

Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and for which no definitive cure is currently available. Cellular functions in mouse and human tissues can be restored after fusion of bone m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altarche-Xifro, Wassim, di Vicino, Umberto, Muñoz-Martin, Maria Isabel, Bortolozzi, Analía, Bové, Jordi, Vila, Miquel, Cosma, Maria Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919540/ https://www.ncbi.nlm.nih.gov/pubmed/27428421 http://dx.doi.org/10.1016/j.ebiom.2016.04.016

Ejemplares similares

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
por: Carballo-Carbajal, Iria, et al.
Publicado: (2019)

Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease
por: Pavia-Collado, Rubén, et al.
Publicado: (2022)

Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy
por: Miquel-Rio, Lluis, et al.
Publicado: (2022)

Endogenous Mobilization of Bone-Marrow Cells Into the Murine Retina Induces Fusion-Mediated Reprogramming of Müller Glia Cells
por: Pesaresi, Martina, et al.
Publicado: (2018)

Controlled ploidy reduction of pluripotent 4n cells generates 2n cells during mouse embryo development
por: Frade, João, et al.
Publicado: (2019)

Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson’s Disease
por: Duperrier, Sandra, et al.
Publicado: (2022)

Rescue of hematopoietic stem/progenitor cells formation in plcg1 zebrafish mutant
por: Ferri-Lagneau, Karine F., et al.
Publicado: (2019)

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease
por: Barallobre, M J, et al.
Publicado: (2014)

The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2021)

microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease
por: Yao, Yufang, et al.
Publicado: (2023)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015)

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
por: Recasens, Ariadna, et al.
Publicado: (2018)

The CD4(+)AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function
por: Skorska, Anna, et al.
Publicado: (2015)

Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson’s disease
por: Gao, Qing, et al.
Publicado: (2017)

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
por: Doi, Daisuke, et al.
Publicado: (2020)

Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
por: Alarcón-Arís, Diana, et al.
Publicado: (2020)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
por: Cai, Hua-Ying, et al.
Publicado: (2021)

Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
por: Karimi, Aliasghar, et al.
Publicado: (2021)

TNFα Rescues Dendritic Cell Development in Hematopoietic Stem and Progenitor Cells Lacking C/EBPα
por: Anirudh, Subramanian, et al.
Publicado: (2020)

Rescue of Alzheimer’s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells
por: Mishra, Priyanka, et al.
Publicado: (2023)

Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson’s Disease Model
por: Precious, Sophie V., et al.
Publicado: (2020)

Sulfatase modifying factor 1–mediated fibroblast growth factor signaling primes hematopoietic multilineage development
por: Buono, Mario, et al.
Publicado: (2010)

The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
por: Miquel-Rio, Lluis, et al.
Publicado: (2023)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Pretreatment with Perlecan-Conjugated Laminin-E8 Fragment Enhances Maturation of Grafted Dopaminergic Progenitors in Parkinson’s Disease Model
por: Adachi, Hiromasa, et al.
Publicado: (2022)

Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells
por: Theka, Ilda, et al.
Publicado: (2019)

Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?
por: D’Amelio, Marcello, et al.
Publicado: (2023)

Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models
por: Li, Bing, et al.
Publicado: (2021)

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
por: Que, Rongfang, et al.
Publicado: (2021)

Neck infection after allogenic hematopoietic progenitors transplantation
por: Mensa, Josep, et al.
Publicado: (2020)

A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease
por: Nakamura, Ryota, et al.
Publicado: (2023)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Direct Differentiation of Adult Ocular Progenitors into Striatal Dopaminergic Neurons
por: Ahmad, Iqbal, et al.
Publicado: (2015)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pv3c9sjkorh4sqlf7vng2upko5